Westside Investment Management’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.74M | Sell |
472,790
-20,860
| -4% | -$297K | 1.25% | 16 |
|
|
2025
Q1 | $6.41M | Sell |
493,650
-81,572
| -14% | -$1.06M | 1.36% | 13 |
|
|
2024
Q4 | $7.66M | Sell |
575,222
-43,453
| -7% | -$579K | 1.61% | 12 |
|
|
2024
Q3 | $3.71M | Buy |
618,675
+33,275
| +6% | +$200K | 0.79% | 32 |
|
|
2024
Q2 | $1.93M | Buy |
585,400
+11,440
| +2% | +$37.6K | 0.44% | 56 |
|
|
2024
Q1 | $2.15M | Buy |
573,960
+10,850
| +2% | +$40.7K | 0.52% | 48 |
|
|
2023
Q4 | $2.47M | Buy |
563,110
+34,800
| +7% | +$152K | 0.63% | 37 |
|
|
2023
Q3 | $2.2M | Buy |
528,310
+9,059
| +2% | +$37.8K | 0.63% | 39 |
|
|
2023
Q2 | $1.81M | Buy |
519,251
+1,950
| +0.4% | +$6.81K | 0.51% | 51 |
|
|
2023
Q1 | $1.99M | Sell |
517,301
-36,900
| -7% | -$142K | 0.58% | 44 |
|
|
2022
Q4 | $3.01K | Buy |
554,201
+81,850
| +17% | +$444 | 0.01% | 223 |
|
|
2022
Q3 | $2.04K | Buy |
472,351
+126,801
| +37% | +$548 | ﹤0.01% | 241 |
|
|
2022
Q2 | $3.06K | Buy |
345,550
+103,330
| +43% | +$916 | 0.01% | 228 |
|
|
2022
Q1 | $3.21K | Buy |
242,220
+123,695
| +104% | +$1.64K | 0.01% | 228 |
|
|
2021
Q4 | $3.03K | Buy |
118,525
+13,225
| +13% | +$338 | 0.01% | 219 |
|
|
2021
Q3 | $3.05K | Buy |
105,300
+3,500
| +3% | +$101 | 0.01% | 217 |
|
|
2021
Q2 | $3.7K | Buy |
101,800
+15,275
| +18% | +$556 | 0.01% | 208 |
|
|
2021
Q1 | $4.29K | Buy |
86,525
+2,625
| +3% | +$130 | 0.01% | 196 |
|
|
2020
Q4 | $4.74K | Buy |
83,900
+850
| +1% | +$48 | 0.01% | 156 |
|
|
2020
Q3 | $4.6K | Buy |
83,050
+1,000
| +1% | +$55 | ﹤0.01% | 163 |
|
|
2020
Q2 | $3.17K | Buy |
82,050
+34,300
| +72% | +$1.33K | ﹤0.01% | 151 |
|
|
2020
Q1 | $195 | Buy |
+47,750
| New | +$195 | ﹤0.01% | 236 |
|